Harvard dean to join PhRMA team

"I am thrilled to take on this leadership role for PhRMA at a time when medical science and transformative biomedical advances promise new therapies for men, women and children," Chin said in a statement.

"My vision includes establishing PhRMA as the premiere convener of those individuals who can serve as a catalyst for advancing drug discovery and development, regulatory sciences and collaborative partnerships."

Chin spent 25 years in academia before joining Eli Lilly in 1999, where his team fostered more than 100 clinical candidates. His latest stint at Harvard Medical School began in 2010; he previously taught there as a professor.